Last reviewed · How we verify
NCT04232358
Resistance Training and Injection Treatment for Achilles Enthesopathy
NA trial testing Corticosteroid injection in Achilles Entesopathy in 50 participants. Participants enrolled and being followed up; not accepting new ones.
4 November 2024
Quick facts
| Lead sponsor | Bispebjerg Hospital |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 4 May 2021 |
| Primary completion | 4 November 2024 |
| Estimated completion | 4 May 2025 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Corticosteroid injection
- Local anesthesia injections — full drug profile →
Conditions studied
- Achilles Entesopathy — all drugs for Achilles Entesopathy →
Sponsor
Bispebjerg Hospital
Who can join
Adults 18 to 65, any sex, with Achilles Entesopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Achilles enthesopathy is a common and often long-lasting injury among exercising individuals. Very little is known regarding the effect of different treatment strategies. The purpose of the study is to evaluate two treatment strategies for achilles enthesopathy: Resistance training and restricted loading + corticosteroid injection compared to resistance training and restricted loading + local anesthesia injection. 50 patients with achilles enthesopathy are randomly assigned to the two treatment groups in this double blinded RCT.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04232358
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Corticosteroid injection
Trials testing the same drug.
- NCT06376981 — Hyaluronic Acid in Shoulder Tendinopathy · Phase 3 · recruiting
- NCT06494657 — Frozen Shoulder and Glucose Following Corticosteroid Injection · not yet recruiting
- NCT05882786 — Corticosteroid Injection Versus Tendon Dry Needling for Subacromial Impingement Syndrome · NA · unknown
- NCT05698563 — Intermetatarsal Bursitis in Patients With Rheumatoid Arthritis · NA · terminated
- NCT04929951 — The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis · Phase 1 · recruiting
Other Bispebjerg Hospital trials
Trials by the same sponsor.
- NCT06872060 — The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance. · NA · not yet recruiting
- NCT07373587 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy · NA · not yet recruiting
- NCT07123558 — Anal Cancer Prevention in High-Risk Categories of Men Who Have Sex With Men · NA · not yet recruiting
- NCT07124338 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy, a Feasibili · NA · active not recruiting
- NCT07096648 — Alert Burden When Monitoring Patients at Home · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04232358 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bispebjerg Hospital
- Last refreshed: 12 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04232358.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing